Renal oncocytoma
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]
Synonyms and keywords: Oncocytoma of kidney, proximal tubular adenoma, oncocytic adenoma, oncocytic renal adenoma
Overview
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]
Overview
Renal oncocytoma is a relatively rare and benign tumor. The incidence of is approximately 3% to 7% of solid renal resected tumors and it is more common in male patients. The majority of patients with renal oncocytoma are asymptomatic. Symptoms of renal oncocytoma include hematuria, flank pain, abdominal or flank mass and weight loss. Physical examination of patients with renal oncocytoma is usually normal. An abdominal or flank mass may be palpayed during physical examination. Surgery is the mainstay of treatment for renal oncocytoma. Although the nature of renal oncocytoma is benign and the prognosis is excellent, since the definite diagnosis can not be obtained before operation, surgical resection is a choice of treatment.
Historical perspective
Renal oncocytoma was first discovered by Zippel, in 1942 and Klein and Valensi were the first to demonstrate the pathologic characteristics of renal oncocytoma as “proximal tubular adenoma with oncocytic features” in 1976.
Classification
There is no established system for the classification of renal oncocytoma.
Pathophysiology
The exact pathogenesis of renal oncocytoma is not completely understood. Although some mechanisms are suggested in the pathogenesis of this disease that include, lossing of chromosome 1 and dysfunction of mitochondrial enzymes which is caused by alterations in the mitochondrial DNA. DNA diploidy is seen in 96% of patients with renal oncocytomas. The development of renal oncocytoma is the result of multiple genetic mutations such as deletion of chromosome 1, deletion of the sex chromosome, translocation of chromosome 11q13, sporadic or no chromosomal alteration. Renal oncocytoma can be associated with familial renal oncocytoma or Birt-Hogg-Dube syndrome. On gross pathology, tan to brown surface color , well-encapsulated with a thick, well-defined, fibrous capsule, central scar, and homogeneous appearance without any hemorrhage or necrosis inside it in the tumor cut are characteristic findings of renal oncocytoma. On microscopichistopathological analysis, renal oncocytoma characterized by “oncocytes”. They are large, round to polygonal neoplastic cells accompanied by eosinophilicgranular cytoplasm and are organized in nested or organoid pattern. Although, renal oncocytoma is benign, atypia, prominent nucleoli, and pleomorphism may seen in microscopic examination.
Causes
There are no established causes for renal oncocytoma.
Differential Diagnosis
Renal oncocytoma must be differentiated from other diseases that cause abdominal mass, abdominal pain and hematuria such as wilms tumor, renal cell carcinoma, rhabdoid kidney disease, polycystic kidney disease, and other urogenital mass.
Epidemiology and Demographics
The incidence of renal oncocytoma is approximately 3% to 7% of solid renal resected tumors. Patients of all age groups may develop renal oncocytoma. The age of patients can be differ from 10 to 94 years. The incidence of renal oncocytoma increases with age; the median age at the time of surgery is 62 to 68 years. Males are more commonly affected by renal oncocytoma than females. The male to female ratio is approximately 2 to 1.
Risk Fctors
Patients with tuberous sclerosis complex and Birt-Hogg-Dube syndrome are at an elevated risk of developing renal oncocytomas (often bilateral).
Screening
There is insufficient evidence to recommend routine screening for renal oncocytoma.
Natural History, Complications and Prognosis
The median age at the time of surgery is 62 to 68 years. In 10% to 32% of patients with renal oncocytoma, coexcitente RCC are seen. Prognosis is generally excellent, There are only two cases of metastatic renal oncocytoma were reported. Since the definite diagnosis is maintain just after surgery, most of patients are undergone operation.
Diagnosis
History and Symptoms
The majority of patients with renal oncocytoma are asymptomatic. Symptoms are seen in almost only 17% to 21% of patients with renal oncocytoma. Symptoms of renal oncocytoma include hematuria, flank pain, abdominal or flank mass and weight loss.
Physical Examination
Physical examination of patients with renal oncocytoma is usually normal. An abdominal or flank mass may be palpayed during physical examination.
Laboratory Findings
Some patients with renal oncocytoma may have hematuria, in their urine analysis.
X Ray
X-ray is rarely done for the diagnosis of renal oncocytoma.
CT Scan
Abdominal CT scan may be helpful in the diagnosis of renal oncocytoma. Findings on CT scan suggestive ofrenal oncocytoma include solid renal lesion, centralscar (stellate scar), hypervascularity, hypodenseity ( most of the time), and homogenous enhancements.
MRI
Renal MRI may be helpful in the diagnosis of renal oncocytoma. Findings on MRI suggestive of renal oncocytoma include central scar, satellite pattern, pseudo-capsule, hypointensity in T1 and hyperintensity in T2 weighted images. Although, none of these characteristics can differentiate between renal oncocytoma and RCC.
Ultrasound
Renal ultrasound in renal oncocytoma patients may show: solid mass ( help to distinguish solid from cystic mass), central scarring, calcification, central necrosis which none of them characteristics for indicating a specific renal lesion.
Other Imaging Findings
Renal angiography may be helpful in the diagnosis of renal oncocytoma. The “spoke-wheeled” appearance, lucent rim sign, homogeneous capillary flush in the nephrogram phase, lack of wild neoplastic vessels,and both hypovascular or hypervascular may seen on angiography of patients with renal oncocytoma. Although, none of them are specific for renal oncocytoma and they also may seen in RCCs.
Other Diagnostic Studies
Renal mass biopsy may be helpful in the diagnosis of renal oncocytoma. However, distinguishing between oncocytoma and RCC by biopsy is difficult. Since this method only reserved for patients who are at high risk for an operation like very elderly or extremely sick patients. Some complications may happen during renal mass biopsy which are perirenal hemorrhage, pneumothorax ( during biopsy of upper pole tumors) and tumor seeding.
Treatment
Medical Therapy
The mainstay of therapy for renal oncocytoma is surgery.
Surgery
Surgery is the mainstay of treatment for renal oncocytoma. Although the nature of renal oncocytoma is benign and the prognosis is excellent, since the definite diagnosis can not be obtained before operation, surgical resection is a choice of treatment. Best option for surgery differs based on the mass characteristics, partial nephrectomy is done in polar lesions smaller than 4 cm in a normal contralateral kidney while, large solid renal masses which destroy most part of renal tissue or patients who have not candidate for nephron-sparing surgery are reserved for total nephrectomy.
Primary Prevention
There are no established measures for the primary prevention of renal oncocytoma.
Secondary Prevention
There are no established measures for the secondary prevention of renal oncocytoma.
References
Historical Perspective
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
Renal oncocytoma was first discovered by Zippel, in 1942 and Klein and Valensi were the first to demonstrate the pathologic characteristics of renal oncocytoma as “proximal tubular adenoma with oncocytic features” in 1976.
Historical Perspective
Discovery
- Renal oncocytoma was first discovered by Zippel, in 1942.[1]
- In 1976, Klein and Valensi were the first to demonstrate the pathologic characteristics of renal oncocytoma as “proximal tubular adenoma with oncocytic features”.[2]
References
- ↑ Stephen M. Schatz & Michael M. Lieber (2003). “Update on oncocytoma”. Current urology reports. 4 (1): 30–35. PMID 12537936. Unknown parameter
|month=ignored (help) - ↑ M. J. Klein & Q. J. Valensi (1976). “Proximal tubular adenomas of kidney with so-called oncocytic features. A clinicopathologic study of 13 cases of a rarely reported neoplasm”. Cancer. 38 (2): 906–914. PMID 975006. Unknown parameter
|month=ignored (help)
Classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
There is no established system for the classification of renal oncocytoma.
Classification
There is no established system for the classification of renal oncocytoma.
References
Pathophysiology
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]
Overview
The exact pathogenesis of renal oncocytoma is not completely understood. Although some mechanisms are suggested in the pathogenesis of this disease that include, lossing of chromosome 1 and dysfunction of mitochondrial enzymes which is caused by alterations in the mitochondrial DNA. DNA diploidy is seen in 96% of patients with renal oncocytomas. The development of renal oncocytoma is the result of multiple genetic mutations such as deletion of chromosome 1, deletion of the sex chromosome, translocation of chromosome 11q13, sporadic or no chromosomal alteration. Renal oncocytoma can be associated with familial renal oncocytoma or Birt-Hogg-Dube syndrome. On gross pathology, tan to brown surface color , well-encapsulated with a thick, well-defined, fibrous capsule, central scar, and homogeneous appearance without any hemorrhage or necrosis inside it in the tumor cut are characteristic findings of renal oncocytoma. On microscopic histopathological analysis, renal oncocytoma characterized by “oncocytes”. They are large, round to polygonal neoplastic cells accompanied by eosinophilic granular cytoplasm and are organized in nested or organoid pattern. Although, renal oncocytoma is benign, atypia, prominent nucleoli, and pleomorphism may seen in microscopic examination.
Pathophysiology
Pathogenesis
- The exact pathogenesis of renal oncocytoma is not completely understood.
- The mechanisms which are suggested in the pathogenesis of renal oncocytoma include:[1][2][3][4]
- Lossing of chromosome 1
- Dysfunction of mitochondrial enzymes which is caused by alterations in the mitochondrial DNA
Genetics
DNA diploidy is seen in 96% of patients with renal oncocytomas.[5][6][7]
The development of renal oncocytoma is the result of multiple genetic mutations such as:[8][9][10][1][2][11]
- Deletion of chromosome 1
- Deletion of the sex chromosome
- Translocation of chromosome 11q13
- Sporadic or no chromosomal alteration
Associated Conditions
Conditions associated with renal oncocytoma include:[12][13]
Note: Birt-Hogg-Dube syndrome is an autosomal dominant syndrome which is presented with different types of dermatologic diseases and renal epithelial tumors such as renal oncocytoma and RCCs.
Gross Pathology
On gross pathology, tan to brown surface color , well-encapsulated with a thick, well-defined, fibrous capsule, central scar, and homogeneous appearance without any hemorrhage or necrosis inside it in the tumor cut are characteristic findings of renal oncocytoma.[14][15][16][17][18][19]


Microscopic Pathology
On microscopic histopathological analysis, renal oncocytoma characterized by “oncocytes”. They are large, round to polygonal neoplastic cells accompanied by eosinophilic granular cytoplasm and are organized in nested or organoid pattern. Although, renal oncocytoma is benign, atypia, prominent nucleoli, and pleomorphism may seen in microscopic examination.[20][21][22][23][24]


References
- ↑ 1.0 1.1 Thrash-Bingham, Catherine A.; Salazar, Hernando; Greenberg, Richard E.; Tartof, Kenneth D. (1996). “Loss of heterozygosity studies indicate that chromosome arm 1p harbors a tumor suppressor gene for renal oncocytomas”. Genes, Chromosomes and Cancer. 16 (1): 64–67. doi:10.1002/(SICI)1098-2264(199605)16:1<64::AID-GCC9>3.0.CO;2-1. ISSN 1045-2257.
- ↑ 2.0 2.1 Dijkhuizen, T.; van den Berg, E.; Störkel, S.; de Vries, B.; van der Veen, A.Y.; Wilbrink, M.; Geurts van Kessel, A.; de Jong, B. (1997). “Renal oncocytoma with t(5;12;11), der(1)t(1;8) and add(19): “true” oncocytoma or chromophobe adenoma?”. International Journal of Cancer. 73 (4): 521–524. doi:10.1002/(SICI)1097-0215(19971114)73:4<521::AID-IJC11>3.0.CO;2-C. ISSN 0020-7136.
- ↑ Neuhaus, Christine; Dijkhuizen, T.; van den Berg, E.; Störkel, S.; Stöckle, M.; Mensch, B.; Huber, C.; Decker, H.-J. (1997). “Involvement of the chromosomal region 11q13 in renal oncocytoma: Case report and literature review”. Cancer Genetics and Cytogenetics. 94 (2): 95–98. doi:10.1016/S0165-4608(96)00205-1. ISSN 0165-4608.
- ↑ C. Welter, G. Kovacs, G. Seitz & N. Blin (1989). “Alteration of mitochondrial DNA in human oncocytomas”. Genes, chromosomes & cancer. 1 (1): 79–82. PMID 2487148. Unknown parameter
|month=ignored (help) - ↑ M. R. Licht, A. C. Novick, R. R. Tubbs, E. A. Klein, H. S. Levin & S. B. Streem (1993). “Renal oncocytoma: clinical and biological correlates”. The Journal of urology. 150 (5 Pt 1): 1380–1383. PMID 8411404. Unknown parameter
|month=ignored (help) - ↑ J. Hartwick, R. Warren; El-Naggar, Adel K.; Ro, Jae Y.; Srigley, John R.; Mclemore, Donia D.; Jones, Edward C.; Grignon, David J.; Thomas, M. Jane; Ayala, Alberto G. (1992). “Renal Oncocytoma and Granular Renal Cell Carcinoma: A Comparative Clinicopathologic and DNA Flow Cytometric Study”. American Journal of Clinical Pathology. 98 (6): 587–593. doi:10.1093/ajcp/98.6.587. ISSN 1943-7722.
- ↑ L. Fuzesi, B. Gunawan, S. Braun, F. Bergmann, A. Brauers, P. Effert & C. Mittermayer (1998). “Cytogenetic analysis of 11 renal oncocytomas: further evidence of structural rearrangements of 11q13 as a characteristic chromosomal anomaly”. Cancer genetics and cytogenetics. 107 (1): 1–6. PMID 9809026. Unknown parameter
|month=ignored (help) - ↑ L. Fuzesi, B. Gunawan, S. Braun, F. Bergmann, A. Brauers, P. Effert & C. Mittermayer (1998). “Cytogenetic analysis of 11 renal oncocytomas: further evidence of structural rearrangements of 11q13 as a characteristic chromosomal anomaly”. Cancer genetics and cytogenetics. 107 (1): 1–6. PMID 9809026. Unknown parameter
|month=ignored (help) - ↑ Presti, Joseph C.; Moch, Holger; Reuter, Victor E.; Huynh, Danh; Waldman, Frederic M. (1996). “Comparative genomic hybridization for genetic analysis of renal oncocytomas”. Genes, Chromosomes and Cancer. 17 (4): 199–204. doi:10.1002/(SICI)1098-2264(199612)17:4<199::AID-GCC1>3.0.CO;2-Z. ISSN 1045-2257.
- ↑ van den Berg, E.; Dijkhuizen, T.; Störkel, S.; Brutel de la Rivière, G.; Dam, A.; Mensink, H.J.A.; Oosterhuis, J.W.; de Jong, B. (1995). “Chromosomal changes in renal oncocytomas Evidence that t(5;11)(q35;q13) may characterize a second subgroup of oncocytomas”. Cancer Genetics and Cytogenetics. 79 (2): 164–168. doi:10.1016/0165-4608(94)00142-X. ISSN 0165-4608.
- ↑ R. J. Sinke, T. Dijkhuizen, B. Janssen, D. Olde Weghuis, G. Merkx, E. van den Berg, E. Schuuring, A. M. Meloni, B. de Jong & A. Geurts van Kessel (1997). “Fine mapping of the human renal oncocytoma-associated translocation (5;11)(q35;q13) breakpoint”. Cancer genetics and cytogenetics. 96 (2): 95–101. PMID 9216713. Unknown parameter
|month=ignored (help) - ↑ G. Weirich, G. Glenn, K. Junker, M. Merino, S. Storkel, I. Lubensky, P. Choyke, S. Pack, M. Amin, M. M. Walther, W. M. Linehan & B. Zbar (1998). “Familial renal oncocytoma: clinicopathological study of 5 families”. The Journal of urology. 160 (2): 335–340. PMID 9679872. Unknown parameter
|month=ignored (help) - ↑ J. R. Toro, G. Glenn, P. Duray, T. Darling, G. Weirich, B. Zbar, M. Linehan & M. L. Turner (1999). “Birt-Hogg-Dube syndrome: a novel marker of kidney neoplasia”. Archives of dermatology. 135 (10): 1195–1202. PMID 10522666. Unknown parameter
|month=ignored (help) - ↑ Moch, Holger; Cubilla, Antonio L.; Humphrey, Peter A.; Reuter, Victor E.; Ulbright, Thomas M. (2016). “The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours”. European Urology. 70 (1): 93–105. doi:10.1016/j.eururo.2016.02.029. ISSN 0302-2838.
- ↑ Amin, Mahul B.; Crotty, Thomas B.; Tickoo, Satish K.; Farrow, George M. (1997). “Renal Oncocytoma: A Reappraisal of Morphologic Features with Clinicopathologic Findings in 80 Cases”. The American Journal of Surgical Pathology. 21 (1): 1–12. doi:10.1097/00000478-199701000-00001. ISSN 0147-5185.
- ↑ Perez-Ordonez, Bayardo; Hamed, Ghiath; Campbell, Steve; Erlandson, Robert; Russo, Paul; Gaudin, Paul; Reuter, Victor (1997). American Journal of Surgical Pathology. 21 (8): 871–883. doi:10.1097/00000478-199708000-00001. ISSN 0147-5185. Missing or empty
|title=(help) - ↑ Trpkov, Kiril; Yilmaz, Asli; Uzer, Dina; Dishongh, Kristin M; Quick, Charles M; Bismar, Tarek A; Gokden, Neriman (2010). “Renal oncocytoma revisited: a clinicopathological study of 109 cases with emphasis on problematic diagnostic features”. Histopathology. 57 (6): 893–906. doi:10.1111/j.1365-2559.2010.03726.x. ISSN 0309-0167.
- ↑ B. Perez-Ordonez, G. Hamed, S. Campbell, R. A. Erlandson, P. Russo, P. B. Gaudin & V. E. Reuter (1997). “Renal oncocytoma: a clinicopathologic study of 70 cases”. The American journal of surgical pathology. 21 (8): 871–883. PMID 9255250. Unknown parameter
|month=ignored (help) - ↑ F. Bertoni, C. Ferri, P. Bacchini, G. Corrado, A. Benati, D. Mannini & F. Corrado (1989). “Oncocytoma and low-grade oncocytic carcinoma of the kidney”. European urology. 16 (2): 101–109. PMID 2714326.
- ↑ B. Perez-Ordonez, G. Hamed, S. Campbell, R. A. Erlandson, P. Russo, P. B. Gaudin & V. E. Reuter (1997). “Renal oncocytoma: a clinicopathologic study of 70 cases”. The American journal of surgical pathology. 21 (8): 871–883. PMID 9255250. Unknown parameter
|month=ignored (help) - ↑ Barnes, C. Allan; Beckman, Edwin N. (1983). “Renal Oncocytoma and Its Congeners”. American Journal of Clinical Pathology. 79 (3): 312–318. doi:10.1093/ajcp/79.3.312. ISSN 1943-7722.
- ↑ H. Choi, U. A. Almagro, J. T. McManus, D. H. Norback & S. C. Jacobs (1983). “Renal oncocytoma. A clinicopathologic study”. Cancer. 51 (10): 1887–1896. PMID 6831354. Unknown parameter
|month=ignored (help) - ↑ M. B. Amin, T. B. Crotty, S. K. Tickoo & G. M. Farrow (1997). “Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases”. The American journal of surgical pathology. 21 (1): 1–12. PMID 8990136. Unknown parameter
|month=ignored (help) - ↑ J. N. Eble & M. T. Hull (1984). “Morphologic features of renal oncocytoma: a light and electron microscopic study”. Human pathology. 15 (11): 1054–1061. PMID 6490001. Unknown parameter
|month=ignored (help)
Causes
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]
Overview
There are no established causes for renal oncocytoma.
Causes
There are no established causes for renal oncocytoma.
References
Differentiating Renal oncocytoma from other Diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]Sargun Singh Walia M.B.B.S.[4]
Overview
Renal oncocytoma must be differentiated from other diseases that cause abdominal mass, abdominal pain and hematuria such as wilms tumor, renal cell carcinoma, rhabdoid kidney disease, polycystic kidney disease, and other urogenital mass.
Differentiating renal oncocytoma from other Diseases
Renal oncocytoma must be differentiated from other diseases that cause abdominal mass, abdominal pain and hematuria such as Wilms tumor, renal cell carcinoma, rhabdoid kidney disease, polycystic kidney disease, and other urogenital mass..
| Genetic differentiation between renal oncocytoma and RCC subtypes | |||||||||||||||||||||||||||||||||||||||||||||||||
| Common chromosomal alteration | |||||||||||||||||||||||||||||||||||||||||||||||||
| 1. Deletion of chromosome 1 and X/Y
2. A balanced translocation involving 11q13 3. Sporadic or no chromosomal alterations | Loss of heterozygosity chromosome 1, 2, 6, 10, 13,17, and 21 | Additional copies of chromosomes 7, 12, and 17 | Loss of heterozygosity chromosome 3p | ||||||||||||||||||||||||||||||||||||||||||||||
| Oncocytoma | chromophobe RCC | Papillary RCC | Nonpapillary RCC | ||||||||||||||||||||||||||||||||||||||||||||||
Differentiating renal oncocytoma from other diseases on the basis of abdominal pain, hematuria, and headache
Renal oncocytomas should be differentiated from other diseases that cause abdominal pain, hematuria and headache. The differentials include the following:[1][2][3][4][5][6][7][8][9]
| S.No. | Disease | Symptoms | Signs | Diagnosis | Comments | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Abdominal Pain | Hematuria | Headache | Abdominal mass | Abdominal tenderness | Ultrasonography | CT scan | Histology | |||
| 1. | Renal oncocytoma | +/- | + /- | – | +/- | +/- | Renal ultrasound in renal oncocytoma patients may show: | Abdominal CT scan may be helpful in the diagnosis of renal oncocytoma. Findings on CT scan suggestive of renal oncocytoma include: |
|
|
| 2. | Wilms tumor | + | + | – | + | + |
|
|
|
|
| 3. | Renal cell carcinoma | + | + | +/- | + | – |
|
Both CT and MRI may be used to detect neoplastic masses that may define renal cell carcinoma or metastasis of the primary cancer. CT scan and use of intravenous (IV) contrast is generally used for work-up and follow-up of patients with renal cell carcinoma. | The histological pattern of renal cell carcinoma depends whether it is papillary, chromophobe or collecting duct renal cell carcinoma. | |
| 4. | Rhabdoid kidney disease | + | + | – | + | – |
|
|
|
|
| 5. | Polycystic kidney disease | + | + | + (from hypertension) | + | – |
Ultrasound may be helpful in the diagnosis of polycystic kidney disease. Findings on an ultrasound diagnostic of polycystic kidney disease include: |
Renal CT scan may be helpful in the diagnosis of polycystic kidney disease. Findings on CT scan diagnostic of ADPKD include:
|
|
|
| 6. | Pheochromocytoma | – | – | + (as a part of the hypertension paroxysm) | – | – |
|
The following findings may be observed on CT scan:
|
|
|
| 7. | Burkitt lymphoma | +/- (in non-endemic or sporadic form of the disease) | – | – | – | – |
|
|
|
|
| 8. | Intussusception | + | – | – | +/- | + |
|
|
|
|
| 9. | Hydronephrosis | + | +/- | – | – | + (CVA tenderness in case of pyelonephritis) |
|
|
|
|
| 10. | Dysplastic kidney | N/A | N/A | N/A | N/A | N/A |
MCDK is usually diagnosed by ultrasound examination before birth.
|
|
||
| 11. | Pediatric Neuroblastoma | + | – | – | +/- | +/- |
|
|
|
|
| 12. | Pediatric Rhabdomyosarcoma | + | +/- | +/- | – | +/- | On CT scan, rhabdomyosarocma is characterized by:
|
|
||
| 13. | Mesoblastic nephroma | + | + | – | + | – |
|
|
||
References
- ↑ D. S. Hartman & R. C. Sanders (1982). “Wilms’ tumor versus neuroblastoma: usefulness of ultrasound in differentiation”. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine. 1 (3): 117–122. PMID 6152936. Unknown parameter
|month=ignored (help) - ↑ J. F. De Campo (1986). “Ultrasound of Wilms’ tumor”. Pediatric radiology. 16 (1): 21–24. PMID 3003660.
- ↑ Sara E. Wobker & Sean R. Williamson (2017). “Modern Pathologic Diagnosis of Renal Oncocytoma”. Journal of kidney cancer and VHL. 4 (4): 1–12. doi:10.15586/jkcvhl.2017.96. PMID 29090117.
- ↑ Bita Geramizadeh, Mahmoud Ravanshad & Marjan Rahsaz (2008). “Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma”. Indian journal of pathology & microbiology. 51 (2): 167–171. PMID 18603673. Unknown parameter
|month=ignored (help) - ↑ Oleksandr N. Kryvenko, Merce Jorda, Pedram Argani & Jonathan I. Epstein (2014). “Diagnostic approach to eosinophilic renal neoplasms”. Archives of pathology & laboratory medicine. 138 (11): 1531–1541. doi:10.5858/arpa.2013-0653-RA. PMID 25357116. Unknown parameter
|month=ignored (help) - ↑ A. M. Amar, G. Tomlinson, D. M. Green, N. E. Breslow & P. A. de Alarcon (2001). “Clinical presentation of rhabdoid tumors of the kidney”. Journal of pediatric hematology/oncology. 23 (2): 105–108. PMID 11216700. Unknown parameter
|month=ignored (help) - ↑ T. I. Han, M. J. Kim, H. K. Yoon, J. Y. Chung & K. Choeh (2001). “Rhabdoid tumour of the kidney: imaging findings”. Pediatric radiology. 31 (4): 233–237. doi:10.1007/s002470000417. PMID 11321739. Unknown parameter
|month=ignored (help) - ↑ S. L. Gooskens, M. E. Houwing, G. M. Vujanic, J. S. Dome, T. Diertens, A. Coulomb-l’Hermine, J. Godzinski, K. Pritchard-Jones, N. Graf & M. M. van den Heuvel-Eibrink (2017). “Congenital mesoblastic nephroma 50 years after its recognition: A narrative review”. Pediatric blood & cancer. 64 (7). doi:10.1002/pbc.26437. PMID 28124468. Unknown parameter
|month=ignored (help) - ↑ Zuo-Peng Wang, Kai Li, Kui-Ran Dong, Xian-Min Xiao & Shan Zheng (2014). “Congenital mesoblastic nephroma: Clinical analysis of eight cases and a review of the literature”. Oncology letters. 8 (5): 2007–2011. doi:10.3892/ol.2014.2489. PMID 25295083. Unknown parameter
|month=ignored (help) - ↑ Jolly RD, Stellwagen E, Babul J, Vodkaĭlo LV, Titov VL, Moldomusaev DM, Maianskiĭ AN (November 1975). “Mannosidosis of Angus Cattle: a prototype control program for some genetic diseases”. Adv Vet Sci Comp Med. 19 (23): 1–21. PMID 1978.
Epidemiology and Demographics
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]
Overview
The incidence of renal oncocytoma is approximately 3% to 7% of solid renal resected tumors. Patients of all age groups may develop renal oncocytoma. The age of patients can be differ from 10 to 94 years. The incidence of renal oncocytoma increases with age; the median age at the time of surgery is 62 to 68 years. Males are more commonly affected by renal oncocytoma than females. The male to female ratio is approximately 2 to 1.
Epidemiology and Demographics
Incidence
Age
- Patients of all age groups may develop renal oncocytoma. The age of patients can be differ from 10 to 94 years.[3][4][5]
- The incidence of renal oncocytoma increases with age; the median age at the time of surgery is 62 to 68 years.[6][7][8]
Gender
- Males are more commonly affected by renal oncocytoma than females. The male to female ratio is approximately 2 to 1.[9]
References
- ↑ Rosenkrantz, Andrew B.; Hindman, Nicole; Fitzgerald, Erin F.; Niver, Benjamin E.; Melamed, Jonathan; Babb, James S. (2010). “MRI Features of Renal Oncocytoma and Chromophobe Renal Cell Carcinoma”. American Journal of Roentgenology. 195 (6): W421–W427. doi:10.2214/AJR.10.4718. ISSN 0361-803X.
- ↑ B. Perez-Ordonez, G. Hamed, S. Campbell, R. A. Erlandson, P. Russo, P. B. Gaudin & V. E. Reuter (1997). “Renal oncocytoma: a clinicopathologic study of 70 cases”. The American journal of surgical pathology. 21 (8): 871–883. PMID 9255250. Unknown parameter
|month=ignored (help) - ↑ H. Choi, U. A. Almagro, J. T. McManus, D. H. Norback & S. C. Jacobs (1983). “Renal oncocytoma. A clinicopathologic study”. Cancer. 51 (10): 1887–1896. PMID 6831354. Unknown parameter
|month=ignored (help) - ↑ M. B. Amin, T. B. Crotty, S. K. Tickoo & G. M. Farrow (1997). “Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases”. The American journal of surgical pathology. 21 (1): 1–12. PMID 8990136. Unknown parameter
|month=ignored (help) - ↑ B. Perez-Ordonez, G. Hamed, S. Campbell, R. A. Erlandson, P. Russo, P. B. Gaudin & V. E. Reuter (1997). “Renal oncocytoma: a clinicopathologic study of 70 cases”. The American journal of surgical pathology. 21 (8): 871–883. PMID 9255250. Unknown parameter
|month=ignored (help) - ↑ B. Perez-Ordonez, G. Hamed, S. Campbell, R. A. Erlandson, P. Russo, P. B. Gaudin & V. E. Reuter (1997). “Renal oncocytoma: a clinicopathologic study of 70 cases”. The American journal of surgical pathology. 21 (8): 871–883. PMID 9255250. Unknown parameter
|month=ignored (help) - ↑ M. B. Amin, T. B. Crotty, S. K. Tickoo & G. M. Farrow (1997). “Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases”. The American journal of surgical pathology. 21 (1): 1–12. PMID 8990136. Unknown parameter
|month=ignored (help) - ↑ Dechet, Christopher B.; Bostwick, David G.; Blute, Michael L.; Bryant, Sandra C.; Zincke, Horst (1999). “RENAL ONCOCYTOMA: MULTIFOCALITY, BILATERALISM, METACHRONOUS TUMOR DEVELOPMENT AND COEXISTENT RENAL CELL CARCINOMA”. Journal of Urology. 162 (1): 40–42. doi:10.1097/00005392-199907000-00010. ISSN 0022-5347.
- ↑ Yusenko, Maria V (2010). “Molecular pathology of renal oncocytoma: A review”. International Journal of Urology. 17 (7): 602–612. doi:10.1111/j.1442-2042.2010.02574.x. ISSN 0919-8172.
Risk Factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]
Overview
Patients with tuberous sclerosis complex and Birt-Hogg-Dube syndrome are at an elevated risk of developing renal oncocytomas (often bilateral).
Risk Factors
Patients with tuberous sclerosis complex and Birt-Hogg-Dube syndrome are at an elevated risk of developing renal oncocytomas (often bilateral).
References
Screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]
Overview
There is insufficient evidence to recommend routine screening for renal oncocytoma.
Screening
There is insufficient evidence to recommend routine screening for renal oncocytoma.
References
Natural History, Complications and Prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2] Shanshan Cen, M.D. [3]
Overview
The median age at the time of surgery is 62 to 68 years. In 10% to 32% of patients with renal oncocytoma, coexcitente RCC are seen. Prognosis is generally excellent, There are only two cases of metastatic renal oncocytoma were reported. Since the definite diagnosis is maintain just after surgery, most of patients are undergone operation.
Natural History, Complications, and Prognosis
Natural History
- The median age at the time of surgery is 62 to 68 years. [1]
- In 10% to 32% of patients with renal oncocytoma, coexcitente RCC are seen.[2][3]
Prognosis
- Prognosis is generally excellent, There are only two cases of metastatic renal oncocytoma were reported.[4][5]
- Since the definite diagnosis is maintain just after surgery, most of patients are undergone operation.[6][1][7]
References
- ↑ 1.0 1.1 Neuzillet, Yann; Lechevallier, Eric; Andre, March; Daniel, Laurent; Nahon, Olivier; Coulange, Christian (2005). “Follow-up of renal oncocytoma diagnosed by percutaneous tumor biopsy”. Urology. 66 (6): 1181–1185. doi:10.1016/j.urology.2005.06.001. ISSN 0090-4295.
- ↑ M. R. Licht, A. C. Novick, R. R. Tubbs, E. A. Klein, H. S. Levin & S. B. Streem (1993). “Renal oncocytoma: clinical and biological correlates”. The Journal of urology. 150 (5 Pt 1): 1380–1383. PMID 8411404. Unknown parameter
|month=ignored (help) - ↑ Dechet, Christopher B.; Bostwick, David G.; Blute, Michael L.; Bryant, Sandra C.; Zincke, Horst (1999). “RENAL ONCOCYTOMA: MULTIFOCALITY, BILATERALISM, METACHRONOUS TUMOR DEVELOPMENT AND COEXISTENT RENAL CELL CARCINOMA”. Journal of Urology. 162 (1): 40–42. doi:10.1097/00005392-199907000-00010. ISSN 0022-5347.
- ↑ Lieber MM (1990). “Renal oncocytoma: prognosis and treatment”. European Urology. 18 Suppl 2: 17–21. PMID 2226597.
- ↑ B. Perez-Ordonez, G. Hamed, S. Campbell, R. A. Erlandson, P. Russo, P. B. Gaudin & V. E. Reuter (1997). “Renal oncocytoma: a clinicopathologic study of 70 cases”. The American journal of surgical pathology. 21 (8): 871–883. PMID 9255250. Unknown parameter
|month=ignored (help) - ↑ Leo Romis, Luca Cindolo, Jean Jacques Patard, Giovanni Messina, Vincenzo Altieri, Laurent Salomon, Claude Clement Abbou, Dominique Chopin, Bernard Lobel & Alexandre de La Taille (2004). “Frequency, clinical presentation and evolution of renal oncocytomas: multicentric experience from a European database”. European urology. 45 (1): 53–57. PMID 14667516. Unknown parameter
|month=ignored (help) - ↑ D. B. Spring, R. C. Ulirsch, W. R. Starke & S. Jr Brown (1985). “Renal oncocytoma followed for eighteen years without resection”. Urology. 26 (4): 389–392. PMID 3901483. Unknown parameter
|month=ignored (help)
Diagnosis
Diagnosis
Staging | History and Symptoms | Physical Examination | Laboratory Findings | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies | Biopsy
Treatment
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
